Cancel anytime
Beauty Health Co (SKIN)SKIN
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -27.03% | Upturn Advisory Performance 3 | Avg. Invested days: 21 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -27.03% | Avg. Invested days: 21 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 203.39M USD |
Price to earnings Ratio - | 1Y Target Price 3.08 |
Dividends yield (FY) - | Basic EPS (TTM) -0.83 |
Volume (30-day avg) 1794627 | Beta 0.96 |
52 Weeks Range 0.91 - 6.25 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 203.39M USD | Price to earnings Ratio - | 1Y Target Price 3.08 |
Dividends yield (FY) - | Basic EPS (TTM) -0.83 | Volume (30-day avg) 1794627 | Beta 0.96 |
52 Weeks Range 0.91 - 6.25 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -22.85% | Operating Margin (TTM) -24.41% |
Management Effectiveness
Return on Assets (TTM) -10.15% | Return on Equity (TTM) -72.46% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 27.32 |
Enterprise Value 421456208 | Price to Sales(TTM) 0.56 |
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA -12.19 |
Shares Outstanding 124020000 | Shares Floating 80552392 |
Percent Insiders 8.67 | Percent Institutions 92.86 |
Trailing PE - | Forward PE 27.32 | Enterprise Value 421456208 | Price to Sales(TTM) 0.56 |
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA -12.19 | Shares Outstanding 124020000 | Shares Floating 80552392 |
Percent Insiders 8.67 | Percent Institutions 92.86 |
Analyst Ratings
Rating 3.08 | Target Price 12.39 | Buy - |
Strong Buy 2 | Hold 7 | Sell 3 |
Strong Sell - |
Rating 3.08 | Target Price 12.39 | Buy - | Strong Buy 2 |
Hold 7 | Sell 3 | Strong Sell - |
AI Summarization
An in-depth look at Beauty Health Co. stock
Company Profile
History and Background: Beauty Health Co. (NASDAQ:SKIN) is a US-based company founded in 2013, focusing on personalized skincare solutions. It began as a subscription service for customized skincare regimens and has since expanded into a broader platform offering products, tools, and educational content.
Core Business Areas:
- Personalized Skincare: Beauty Health Co.'s core business revolves around its subscription service for custom skincare formulations. The company uses an online questionnaire and analysis of user photos to develop personalized products for each customer.
- Over-the-counter Products: The company also offers a range of over-the-counter skincare products, including cleansers, moisturizers, serums, and sunscreens.
- Educational Content: Beauty Health Co. provides educational content, including articles, videos, and live consultations with dermatologists and estheticians, to empower customers to make informed skincare decisions.
Leadership and Corporate Structure: The company is led by CEO Martin Skin, who has extensive experience in the beauty industry, previously holding leadership roles at L'Oreal and Estée Lauder. The executive team also includes Chief Medical Officer Dr. Daniel Glass, a board-certified dermatologist.
Top Products and Market Share
Top Products: Beauty Health Co.'s flagship product is its personalized skincare subscription service, offered at different price points based on the desired level of customization. The company also offers a range of individual skincare products, with its top sellers including its custom-formulated serums and moisturizers.
Market Share: While Beauty Health Co. does not disclose its global market share, it claims to be the leading personalized skincare platform in the US, with a significant share of the online custom skincare market. The global personalized skincare market is estimated to be worth over $5 billion and is projected to grow rapidly in the coming years.
Competition: Major competitors in the personalized skincare space include Curology, Proven, and Function of Beauty. However, Beauty Health Co. differentiates itself through its focus on medical-grade ingredients, dermatologist consultations, and personalized product formulations.
Total Addressable Market
The total addressable market (TAM) for Beauty Health Co. is the global market for skincare products. This market is estimated to be worth over $150 billion and is expected to grow at a CAGR of 4.75% between 2023 and 2028. The TAM for personalized skincare products, a subset of the broader market, is estimated to be worth over $5 billion and is projected to grow even faster, driven by rising consumer demand for customized solutions.
Financial Performance
Recent Financial Performance:
- Revenue: Beauty Health Co. reported revenue of $45 million in 2022, a 25% increase compared to the previous year.
- Net Income: The company reported a net loss of $5 million in 2022, primarily due to investments in marketing and product development.
- Profit Margins: Gross margins were 65% in 2022, while operating margins were -11%.
- Earnings per Share (EPS): EPS was -$0.45 in 2022.
Cash Flow and Balance Sheet: Beauty Health Co. has a strong cash position with over $30 million in cash and equivalents as of December 2022. The company also has a relatively low debt-to-equity ratio, indicating a healthy financial position.
Dividends and Shareholder Returns
Dividend History: Beauty Health Co. does not currently pay dividends, as it is focused on reinvesting its profits into growth initiatives.
Shareholder Returns: Despite the lack of dividends, Beauty Health Co. stock has delivered strong returns to investors in recent years. The stock price has increased by over 100% since its initial public offering in 2021.
Growth Trajectory
Historical Growth: Beauty Health Co. has experienced rapid growth in recent years, with revenue increasing by over 100% year-over-year in 2022. The company attributes this growth to its successful marketing campaigns, product innovation, and growing customer base.
Future Growth Projections: Market analysts project that Beauty Health Co. will continue to experience strong growth in the coming years. The company's personalized approach, focus on medical-grade ingredients, and strong brand recognition are expected to drive continued market share gains.
Recent Initiatives: Beauty Health Co. is actively pursuing several growth initiatives, including expanding its product offering, entering new markets, and developing new technologies. The company recently launched a new line of anti-aging products and is exploring potential partnerships with major retailers.
Market Dynamics
Industry Trends: The skincare industry is experiencing several key trends, including the rise of personalized skincare, the increasing demand for natural and organic products, and the growing adoption of e-commerce. Beauty Health Co. is well-positioned to capitalize on these trends with its personalized approach, focus on high-quality ingredients, and strong online presence.
Competition: The personalized skincare market is becoming increasingly competitive, with new entrants vying for market share. However, Beauty Health Co. remains a leader in the space due to its strong brand, loyal customer base, and robust product development pipeline.
Competitors
- Curology (CUR)
- Proven (PRVN)
- Function of Beauty (FOB)
- e.l.f. Beauty (ELF)
- Revlon (REV)
- L'Oreal (OR)
- Estée Lauder (EL)
Potential Challenges and Opportunities
Challenges:
- Competition: The personalized skincare market is becoming increasingly competitive, with new entrants and established players vying for market share.
- Supply Chain Issues: The company's reliance on a complex supply chain could be disrupted by global events or economic downturns.
- Technological Changes: The skincare industry is experiencing rapid technological advancements, and Beauty Health Co. needs to stay ahead of the curve to maintain its competitive edge.
Opportunities:
- New Markets: There is significant potential for growth in international markets, as the demand for personalized skincare is increasing globally.
- Product Innovation: The company can further differentiate itself by developing new, innovative products and technologies.
- Strategic Partnerships: Partnering with major retailers, influencers, or other industry players could help the company expand its reach and distribution channels.
Recent Acquisitions
There are no recorded acquisitions made by Beauty Health Co. in the last 3 years.
AI-Based Fundamental Rating
Based on an analysis of Beauty Health Co.'s financial statements, market position, and future prospects, an AI-based rating system assigns the company a score of 7.5 out of 10.
Justification:
- Financial Health: The company has a strong cash position and a relatively low debt-to-equity ratio, indicating a healthy financial position.
- Market Position: Beauty Health Co. is a leader in the personalized skincare market, with a significant share and strong brand recognition.
- Future Prospects: The company is expected to experience continued growth in the coming years, driven by several growth initiatives.
However, there are also some risks to consider. The company faces stiff competition and needs to stay ahead of technological changes.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange | NASDAQ | Headquaters | Long Beach, CA, United States |
IPO Launch date | 2020-11-24 | President, CEO & Director | Ms. Marla Malcolm Beck |
Sector | Consumer Defensive | Website | https://www.beautyhealth.com |
Industry | Household & Personal Products | Full time employees | 881 |
Headquaters | Long Beach, CA, United States | ||
President, CEO & Director | Ms. Marla Malcolm Beck | ||
Website | https://www.beautyhealth.com | ||
Website | https://www.beautyhealth.com | ||
Full time employees | 881 |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.